Cargando…
The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection
The emergence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa raises fears of untreatable infections and poses the greatest health threats. Antimicrobial peptides (AMPs) are regarded as the most ideal solution to this menace. In this study, a set of peptides was designed b...
Autores principales: | Mwangi, James, Yin, Yizhu, Wang, Gan, Yang, Min, Li, Ya, Zhang, Zhiye, Lai, Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936460/ https://www.ncbi.nlm.nih.gov/pubmed/31843919 http://dx.doi.org/10.1073/pnas.1909585117 |
Ejemplares similares
-
A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
por: Mohamed, Mohamed F., et al.
Publicado: (2017) -
Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea
por: Kim, Chung-Jong, et al.
Publicado: (2022) -
Systemic Responses of Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Following Exposure to the Antimicrobial Peptide Cathelicidin-BF Imply Multiple Intracellular Targets
por: Liu, Cunbao, et al.
Publicado: (2017) -
Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2022) -
Antibiotics Combinations and Chitosan Nanoparticles for Combating Multidrug Resistance Acinetobacter baumannii
por: Banoub, Nancy G, et al.
Publicado: (2021)